QURE - ユニキュア (uniQure N.V.)

QUREのニュース

   uniQure NV Stock Gives Every Indication Of Being Possible Value Trap  2021/07/01 04:00:22 GuruFocus
Related Stocks: QURE ,
   Gemini Therapeutics defended, Cassava Sciences price target lifted; in todays analyst action  2021/06/23 13:18:32 Seeking Alpha
   uniQure reports positive pivotal trial results for hemophilia gene therapy  2021/06/22 18:18:34 Seeking Alpha
   UniQure to acquire Corlieve Therapeutics in gene-therapy expansion push  2021/06/22 15:40:48 Seeking Alpha
   Enrollment underway in uniQure''s Phase I/II trial of AMT-130 for Huntingtons disease  2021/06/16 11:28:54 Seeking Alpha
   DSMB Recommends UniQure To Continue Huntington's Gene Therapy Trial Unchanged  2021/05/27 15:48:09 Benzinga
The independent Data Safety Monitoring Board (DSMB) has reviewed safety data for the fully enrolled first cohort of ten patients of the Phase 1/2 trial evaluating UniQure NV's (NASDAQ: QURE ) AMT-130 … Full story available on Benzinga.com
   Is Intuitive Surgical the Tesla of Healthcare?  2021/05/27 10:27:00 The Motley Fool
Tesla hopes to dominate the car market using robots and artificial intelligence. Can Intuitive Surgical do the same in the operating room?
   Is Intuitive Surgical the Tesla of Healthcare?  2021/05/27 10:27:00 The Motley Fool
Tesla hopes to dominate the car market using robots and artificial intelligence. Can Intuitive Surgical do the same in the operating room?
   India has held talks with Pfizer, Johnson Johnson, Moderna for COVID-19 vaccines  2021/05/27 07:23:01 Moneycontrol
"Government offered all assistance to have them supply and or manufacture their vaccines in India," the government said in a statement. "No application of any foreign manufacturer for approval is pending with the drugs controller."
   UniQure's Stock Is Trading Higher As FDA Lifts Clinical Hold On Its Hemophilia B Gene Therapy Program  2021/04/26 12:34:09 Benzinga
The FDA has removed the clinical hold on uniQure NV's (NASDAQ: QURE ) hemophilia B gene therapy program after determining the company had satisfactorily addressed all identified issues related to a single patient diagnosed with hepatocellular carcinoma (HCC) in the HOPE-B pivotal trial. Last month, a comprehensive investigation into the case of HCC diagnosed in one patient … Full story available on Benzinga.com
   Uniqure's Hemophilia B Gene Therapy Unlikely To Be Cause Of Liver Cancer Reported In One Patient  2021/03/29 13:26:16 Benzinga
Uniqure NV (NASDAQ: QURE ) has reported results of a comprehensive investigation into the case of hepatocellular carcinoma (HCC) diagnosed in one patient in the HOPE-B pivotal trial of etranacogene dezaparvovec, its hemophilia B gene therapy candidate. What Happened: The trial was put on clinical last year in December , following the submission of a safety report in mid-December relating to a possibly related severe adverse event associated with a preliminary diagnosis of hepatocellular carcinoma in one patient. The results of the investigation found that it is implausible the HCC was caused by etranacogene … Full story available on Benzinga.com
   The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout  2021/02/18 13:14:37 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 17) Advaxis, Inc. (NASDAQ: ADXS ) Angion Biomedica Corp (NASDAQ: ANGN ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Avanos Medical Inc (NYSE: AVNS ) Bausch Health Companies Inc (NYSE: BHC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bioatla Inc (NASDAQ: BCAB ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Chimerix Inc (NASDAQ: CMRX ) China Biologic Products Holdings Inc (NASDAQ: CBPO ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Endo International PLC (NASDAQ: ENDP ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Krystal Biotech Inc (NASDAQ: KRYS ) Laboratory Corp. of America Holdings (NYSE: LH ) Lucira Health Inc (NASDAQ: LHDX ) Nektar Therapeutics (NASDAQ: NKTR ) (announced a $150-million investment by SFJ Pharma for the Phase 2/3 registrational clinical study of BEMPEG plus Keytruda in patients with head and neck cancer) Oncolytics Biotech, Inc. (NASDAQ: ONCY ) (reacted to initiation of coverage by H.C.
   Moving Average Crossover Alert: uniQure  2020/06/01 13:29:00 Zacks Investment Research
uniQure N.V. (QURE) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

calendar